News Articles and Montana BioScience Alliance Newsletters
The University of Montana recently secured $5.1 million in federal grants from the Health Resource and Service Administration, leading to the formation of a new UM Office of Health Research & Partnership. The office will use the HRSA funding for programs to bolster the health care workforce and increase access to quality health care in rural and underserved parts of Montana.
MSU Associate Professor of Molecular Biology Lynn George, Ph.D., was recently awarded a National Institutes of Health Academic Research Enhancement Award (AREA) from the National Institute of Neurological Disorders and Stroke. This three-year, $385,000 grant will support George’s efforts to continue and expand her research on Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. George’s grant proposal scored in the top one percentile, which is laudable, given the highly competitive nature of NIH funding.
Montana State University has appointed Alison Harmon, its dean of the College of Education, Health and Human Development, as its interim vice president of research and economic development.
Billings’ next generation of medical professionals got a chance to get specific Friday, touring booths from dozens of different medical disciplines who all were trying to sway students their way.
University of Montana chemistry Professor Aaron Thomas continues to burnish his credentials as a national leader for helping diversify STEM fields.
Drug makers have been racing at a breakneck pace to develop respiratory syncytial virus (RSV) vaccines this year. On May 3, the U.S. Food and Drug Administration (FDA) announced it has approved Arexvy, the first-ever RSV vaccine for individuals 60 and over.
Information on Small Business Funding Webinar, National Small Business Week, America’s SEED Fund Week — and more
SBIR and STTR grant funding opportunities offer small business entrepreneurs a chance to obtain non-dilutive funding for early-stage research and development. Applications are accepted three times a year. The next deadline is April 5. Omnibus Solicitations. Researcher-initiated ideas are proposed via the SBIR and STTR Omnibus grant solicitations. These FOAs do not specify a topic, though they link to identified topics of interest for each participating awarding component. Most small business applications to NIH are submitted to the Omnibus solicitations. Specific Funding […]
FDA advisers endorsed the safety and efficacy of GSK’s respiratory syncytial virus (RSV) vaccine in older adults, setting up a final mad dash with Pfizer as both companies eye the regulatory finish line with their promising new vaccines.
Researchers from Diaceutics and the Personalized Medicine Coalition has published a special report in JCO Precision Oncology that provides an in-depth look at United States health systems’ efforts to deploy potentially paradigm-shifting targeted and immuno-oncology drugs to improve care for lung cancer patients.
View the Spring 2023 Newsletter now!
View the Winter 2022 Newsletter now!